Fig. 6From: A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemiaValidation of risk score model. A, B Survival analysis between high- and low-risk groups in the validation cohorts (A) and the constituent cohorts of the meta-cohort (B). C time-dependent ROC curve analysis of risk scores in the meta-cohort and the validation cohorts. D, E Univariate and multivariate Cox regression analysis of clinicopathological factors and risk score in the TCGA-LAML cohortBack to article page